Making clinical information accessible and useful on the Internet is fundamental to clinical open innovation, and a well-planned API is essential in the equation.
This idea was reinforced for us at this year’s Open Source Convention (OSCON), held July 22-26 in Portland, Oregon.
As the Tech Lead for the Lilly Clinical Open Innovation Team I was thrilled to have the opportunity to attend this year’s convention with one of our project leads, Dean Sellis. OSCON is about “how the close partnership between business and the open source community is building the future.” And, here at Lilly COI, we are very interested in learning how open methods of development and innovation can have a positive impact on the future of healthcare.
Here are just a few of things we learned at OSCON that we think will help us along the way:
Lilly COI’s mission is to explore the possibilities of transforming drug development through open models of work. We regularly seek knowledge and insights from a wide range of people involved in the healthcare ecosystem, because we believe that only a diverse range of perspectives will help us gain a true understanding of what patients and researchers need. With their valuable insights in mind, we are able to lay some groundwork for the development of solutions that make it easier to access information about clinical trials.
To this end, we are developing a series of exploratory prototypes. The prototypes leverage our open Lilly Clinical Innovation API (LCOI-API), and each focuses on different ways to leverage clinical trial information to benefit those who need it. We invite you to take a look at these prototypes and share your thoughts about them in our Application Lab (App Lab).
Explore the App Lab
In the App Lab, you can explore projects we’re working on, and share your thoughts on how we could improve them.
As you’re looking at the apps, ask yourself:
Does this make it easier for me to find information about clinical trials?
Would it be useful to me as participant in a clinical trial?
Would it be useful to me as the friend or family member of a person looking into clinical research as treatment option?
What additional features and/or fixes could make this better?
Who would dare to pit one fatal disease against another… inside the body of an six-year-old patient? Doctors and researchers in Pennsylvania did just that, and the results were stunning. Using a “dead” version of the HIV virus, they retrained the immune system of a six-year-old Leukemia patient to recognize and then kill tumor cells.
A 65-year-old woman’s brain was cut into 7,400 slices to create the most detailed three-dimensional atlas of the human brain ever made, bringing researchers one step closer to reverse-engineering the brain’s convoluted circuitry. More…
Drew Endy wants to build a programming language for the body.
Endy is the co-director of the International Open Facility Advancing Biotechnology — BIOFAB, for short — where he’s part of a team that’s developing a language that will use genetic data to actually program biological cells. That may seem like the stuff of science fiction, but the project is already underway, and the team intends to open source the language, so that other scientists can use it and modify it and perfect it.